Jacksonville pharmacy owner and accountant indicted over alleged $51 million human immunodeficiency virus (HIV) medication kickback scheme
Published November 15, 2026 · Coverage November 8–14, 2026, Pacific · Lower priority
The U.S. Attorney for the Middle District of Florida announced on November 12 a 31-count indictment charging Charlie Bernard Griffin III with health care fraud and money laundering and Ethelbert Chinenye Nwanegbo, an accountant, with money laundering. According to the indictment, Griffin's First Coast Community Development pharmacy agreed to pay a marketing company $200 per referral for human immunodeficiency virus (HIV) post-exposure prophylaxis medications, payable only if the claim was paid, and used false diagnosis codes showing the patients had, or had been exposed to, HIV or a sexually transmitted disease on prescriptions authorized by a nurse practitioner who never saw the patients. The indictment alleges reimbursements of about $51 million from Medicare, Medicaid and private insurers. These are charges, not findings of guilt.
Background
According to the indictment, the marketing company's representatives collected insurance information while signing people up for free government-sponsored cellphones. Three others, the marketing company's owner, the pharmacist and the nurse practitioner, were charged separately and each agreed to plead guilty.
Who this affects
Hospital outpatient and specialty pharmacies, and prescribers who sign prescriptions generated by third parties.
Why it matters
Inference: the release states that a marketer's being paid per referral based on whether a claim is paid is an illegal kickback. A pharmacy or 340B contract-pharmacy marketing arrangement that pays per referral or per prescription would need its own assessment against that statement; the release does not say such arrangements carry the same exposure.
Recommended action
- Review pharmacy marketing and patient-outreach contracts for payment tied to referrals or paid claims.
Scope and timing
- Authority status
- Allegation
- Responsible owner
- Pharmacy; Compliance; Legal
- Publication date
- 2026-11-12
- Other dates
- Indictment announced November 12, 2026; the indictment's return date is not stated in the release.
Not established
The indictment itself was not retrieved, and its return date is not in the release.
Sources
Complete edition and supplemental material
This article in the complete report →
Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.
Read the entire Enforcement Briefing report →